Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Sep 10;3(17):2679-2687.
doi: 10.1182/bloodadvances.2019000527.

Decoding the role of SOD2 in sickle cell disease

Affiliations
Review

Decoding the role of SOD2 in sickle cell disease

Atinuke M Dosunmu-Ogunbi et al. Blood Adv. .

Abstract

Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a single point mutation in the β-globin gene. As a consequence, deoxygenated hemoglobin polymerizes triggering red blood cell sickling and hemolysis, vaso-occlusion, and ischemia/reperfusion. Allied to these pathologies is the overproduction of reactive oxygen species driven by hemoglobin Fenton chemistry and peroxidase reactions as well as by secondary activation of vascular oxidases, including NAD(P)H oxidase and xanthine oxidase. In addition, hypoxia, produced by sickle red blood cell occlusion, disrupts mitochondrial metabolism and generates excess superoxide through electron leak from the mitochondrial respiratory chain. Superoxide dismutase 2 (SOD2) is a mitochondrial-specific antioxidant enzyme that dismutates superoxide to hydrogen peroxide, which is then converted to water by catalase and glutathione peroxidase. In SCD, the antioxidant defense system is significantly diminished through decreased expression and activity levels of antioxidant enzymes, including superoxide dismutase, catalase, and glutathione peroxidase. From a translational perspective, genetic variants including a missense variant in SOD2 (valine to alanine at position 16) are present in 45% of people with African ancestry and are associated with increased sickle complications. While it is known that there is an imbalance between oxidative species and antioxidant defenses in SCD, much more investigation is warranted. This review summarizes our current understanding of antioxidant defense systems in SCD, particularly focused on SOD2, and provides insight into challenges and opportunities as the field moves forward.

PubMed Disclaimer

Conflict of interest statement

Conflict-of-interest disclosure: A.C.S. receives research funding from Bayer Pharmaceuticals. The remaining authors declare no competing financial interests.

Figures

Figure 1.
Figure 1.
Schematic of SCD-associated oxidative stress pathways and antioxidant systems. In the intravascular space, sickled RBCs undergo hemolysis, releasing hemoglobin (Hb) and heme. Hemoglobin reacts with (1) NO·, forming nitrate (NO3), and (2) hydrogen peroxide (H2O2), producing hydroxyl radical (OH). Endothelial-bound xanthine oxidase (XO) generates superoxide (O2·) and H2O2. Free heme binds to Toll-like receptor 4 (TLR4) producing reactive species through the activation of the NFκB pathway. SOD3 is found in the extracellular compartment and converts O2· to H2O2. In the endothelial cell (EC) cytoplasm, endothelial NO synthase (eNOS) uncoupling and NADPH oxidase 2 (Nox2), Nox4, and Nox5 produce O2·, which is dismutated by SOD1. eNOS normally generates NO·, which is capable of reacting with O2· to form peroxynitrite (ONOO). In the mitochondrial matrix, electrons leaked from complexes I and III of the respiratory chain react with oxygen (O2), forming O2·. SOD2 dismutates O2· to H2O2, which is further broken down to water by catalase (CAT). SOD2 expression and activity is maintained at a precise balance. Overexpression of SOD2 decreases O2· levels and increases H2O2 levels, which are then free to oxidize protein thiols. SOD2 underexpression or dysfunction increases O2· levels, increasing nitration and oxidation of iron sulfur clusters and decreasing metabolism and adenosine triphosphate (ATP) production.

Similar articles

Cited by

References

    1. Ashley-Koch A, Yang Q, Olney RS. Sickle hemoglobin (HbS) allele and sickle cell disease: a HuGE review. Am J Epidemiol. 2000;151(9):839-845. - PubMed
    1. Cardenes N, Corey C, Geary L, et al. . Platelet bioenergetic screen in sickle cell patients reveals mitochondrial complex V inhibition, which contributes to platelet activation. Blood. 2014;123(18):2864-2872. - PMC - PubMed
    1. Chirico EN, Pialoux V. Role of oxidative stress in the pathogenesis of sickle cell disease. IUBMB Life. 2012;64(1):72-80. - PubMed
    1. Nur E, Biemond BJ, Otten HM, Brandjes DP, Schnog JJ; CURAMA Study Group . Oxidative stress in sickle cell disease; pathophysiology and potential implications for disease management. Am J Hematol. 2011;86(6):484-489. - PubMed
    1. Ware RE, de Montalembert M, Tshilolo L, Abboud MR. Sickle cell disease. Lancet. 2017;390(10091):311-323. - PubMed

Publication types

MeSH terms